Navigation Links
Karolinska Development AB Announces Publication of Year End Report for 2009
Date:3/15/2010

STOCKHOLM, March 15, 2010 /PRNewswire/ -- Karolinska Development AB announces publication of its Year End Report 2009 on the company's website.

    Key events during the year:

    Group

    October - December 2009

    - Revenue increased by 8.3 % to 6.9 (6.4) MSEK.
    - Operating income amounted to -22.1 (-249.0) MSEK.
    - Profit after tax amounted to -19.4 (-246.4) MSEK.
    - Income per share before dilution amounted to -0.71 (-10.15) SEK.
    - Investments in portfolio companies during the period amounted to 27.1
      (65.0) MSEK.
    - Cashflow during the period 322.3 (55.5) MSEK.
    - Value of the total portfolio according to the International Private
      Equity and Venture Capital Valuation Board (IPEV Valuation Board)
      guidelines has at the balance sheet date been estimated at 1,512.3 MSEK
      compared to 1,321.8 MSEK as of December 31, 2008.

    January - December 2009

    - Revenue increased by 30.5 % to 30.3 (23.2) MSEK.
    - Operating income amounted to -13.5 (-70.5) MSEK.
    - Profit after tax amounted to -2.6 (-57.7) MSEK.
    - Income per share before dilution amounted to -0.10 (-2.34) SEK.
    - Investments in portfolio companies during the period amounted to 172.4
      (148.6) MSEK.
    - Cash flow during the period amounted to 204.8 (180.3) MSEK.

    Parent company

    January - December 2009

    - Revenue increased by 116.1 % to 6.7 (3.1) MSEK.
    - Operating loss amounted to -101.1 (-61.5) MSEK.

The entire report is available on http://www.karolinskadevelopment.com under Investors> Reports.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies. The portfolio includes a total of 19 potential first in class products. http://www.karolinskadevelopment.com

    Conny Bogentoft
    CEO Karolinska Development
    Tel: +46(0)706-68-61-43,
    e-mail: conny.bogentoft@karolinskadevelopment.com
    Karolinska Development AB (publ)
    Org.nr 556707-5048


SOURCE Karolinska Development AB

Back to top
'/>"/>
SOURCE Karolinska Development AB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
2. 3 new honorary doctors at Karolinska Institutet
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. Karolinska Development Invests in EvoStem Finland Oy
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio
8. Michael J. Fox Receives Honorary Doctorate From Karolinska Institute
9. Michael J. Fox to be made honorary doctor at Karolinska Institutet
10. Isolation of a new gene family essential for early development
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: